LPL Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,350
Closed -$118K 4975
2023
Q4
$118K Sell
10,350
-7,414
-42% -$73.3K ﹤0.01% 4518
2023
Q3
$171K Sell
17,764
-21,333
-55% -$209K ﹤0.01% 4287
2023
Q2
$416K Buy
39,097
+1,073
+3% +$11.5K ﹤0.01% 3587
2023
Q1
$400K Sell
38,024
-164
-0.4% -$1.84K ﹤0.01% 3513
2022
Q4
$473K Buy
38,188
+3,499
+10% +$39.7K ﹤0.01% 3298
2022
Q3
$359K Buy
34,689
+834
+2% +$9.46K ﹤0.01% 3431
2022
Q2
$390K Sell
33,855
-5,060
-13% -$59.6K ﹤0.01% 3417
2022
Q1
$490K Buy
38,915
+4,454
+13% +$51.1K ﹤0.01% 3222
2021
Q4
$402K Sell
34,461
-3,733
-10% -$45.8K ﹤0.01% 3460
2021
Q3
$499K Buy
38,194
+14,229
+59% +$184K ﹤0.01% 3212
2021
Q2
$308K Buy
23,965
+13,965
+140% +$160K ﹤0.01% 3574
2021
Q1
$112K Buy
+10,000
New +$106K ﹤0.01% 3902
2018
Q2
Sell
-25,265
Closed -$326K 3251
2018
Q1
$326K Buy
25,265
+3,533
+16% +$44K ﹤0.01% 2532
2017
Q4
$273K Sell
21,732
-66
-0.3% -$862 ﹤0.01% 2576
2017
Q3
$288K Buy
21,798
+1,674
+8% +$23K ﹤0.01% 2392
2017
Q2
$318K Sell
20,124
-11,421
-36% -$166K ﹤0.01% 2244
2017
Q1
$445K Buy
31,545
+4,744
+18% +$64.9K ﹤0.01% 1908
2016
Q4
$334K Buy
26,801
+1,149
+4% +$14.5K ﹤0.01% 2074
2016
Q3
$340K Sell
25,652
-666
-3% -$7.79K ﹤0.01% 2026
2016
Q2
$290K Buy
+26,318
New +$257K ﹤0.01% 2100

Other funds holding IRWD

LPL Financial's IRWD Position: Q1 2024 in Review

LPL Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 10,350 shares — an estimated $118K sold.

LPL Financial first reported a position in IRWD in Q2 2016 and held it in 20 quarters. The position peaked at $499K in Q3 2021. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • LPL Financial reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • LPL Financial sold 10,350 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $118K.
  • LPL Financial first reported a position in Ironwood Pharmaceuticals in Q2 2016 and held it in 20 quarters.
  • LPL Financial's Ironwood Pharmaceuticals position peaked at $499K in Q3 2021.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on LPL Financial's 13F filing for Q1 2024, filed 10 May 2024.